Multiplex Assay Kit for Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay)

MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-103 97
EDTA plasma(n=5) 80-96 87
heparin plasma(n=5) 89-102 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-102% 96-104% 94-101% 80-90%
EDTA plasma(n=5) 91-105% 80-101% 95-102% 99-105%
heparin plasma(n=5) 89-97% 78-101% 85-98% 80-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CA125) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS One Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice. pubmed:27755542
Tumor Biology KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis pubmed:28651492
Oncotarget Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer Pubmed:29484129
Prognostic value of STC1 expression in ovarian cancer
American Journal of Translational Research Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway Pubmed:35422913
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA154Hu01 Recombinant Carbohydrate Antigen 125 (CA125) Positive Control; Immunogen; SDS-PAGE; WB.
RPA154Hu02 Recombinant Carbohydrate Antigen 125 (CA125) Positive Control; Immunogen; SDS-PAGE; WB.
PAA154Hu01 Polyclonal Antibody to Carbohydrate Antigen 125 (CA125) WB; IHC; ICC; IP.
PAA154Hu02 Polyclonal Antibody to Carbohydrate Antigen 125 (CA125) WB; IHC; ICC; IP.
LAA154Hu81 FITC-Linked Polyclonal Antibody to Carbohydrate Antigen 125 (CA125) WB; IHC; ICC; IF.
LAA154Hu71 Biotin-Linked Polyclonal Antibody to Carbohydrate Antigen 125 (CA125) WB; IHC; ICC.
MAA154Hu22 Monoclonal Antibody to Carbohydrate Antigen 125 (CA125) WB; IHC; ICC; IP.
SEA154Hu ELISA Kit for Carbohydrate Antigen 125 (CA125) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA154Hu Multiplex Assay Kit for Carbohydrate Antigen 125 (CA125) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA154Hu01 ELISA Kit DIY Materials for Carbohydrate Antigen 125 (CA125) Main materials for "Do It (ELISA Kit) Yourself".